Exact Sciences Corp
—- Market cap
- —
- Debt
- +$50.83M
- Cash
- −$964.71M
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $3.71T · View financials
Decision snapshot: EXAS stock price vs NFLX: inconclusive — current versus $1.40K implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at NFLX's multiple
Implied fair value · at EXAS's multiple
Needs EXAS P/S.
Live quote
As of 2024-12-31
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: EXAS FY 2025 (ended Dec 31, 2025) · NFLX FY 2025 (ended Dec 31, 2025).
Trendline
11 fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 100% equity / 0% debt · EV / Revenue 82.26x · EV / EBITDA 262.83x
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
EXACT SCIENCES CORP · implied price per share
Bear
$0.03
Base
$0.03
Bull
$0.04
NETFLIX INC · implied price per share
Bear
$22.51
Base
$26.49
Bull
$30.46
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.02x
0.54x
Net debt / EBITDA
Leverage against operating earnings
-12.66x
0.38x
Cash and equivalents
Liquid reserves on the balance sheet
$964.71M
$9.06B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Guardant Health, Inc.
EXAS vs GH
Natera, Inc.
EXAS vs NTRA
NEOGENOMICS INC
EXAS vs NEO
OPKO HEALTH, INC.
EXAS vs OPK
LABCORP HOLDINGS INC.
EXAS vs LH
QUEST DIAGNOSTICS INC
EXAS vs DGX
Apple Inc.
EXAS vs AAPL
AMAZON COM INC
EXAS vs AMZN
COMCAST CORP
EXAS vs CMCSA
Walt Disney Co
EXAS vs DIS
Warner Bros. Discovery, Inc.
EXAS vs WBD
Live Nation Entertainment, Inc.
EXAS vs LYV
$50.83M
$14.46B
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.